DSIP (Delta Sleep-Inducing Peptide)

The Missing Biology: No Gene, No Precursor, No Receptor

UKPWritten and published by UK Peptides2 min readUpdated 3 cited sources

The short answer

No DSIP gene has been isolated, no precursor protein identified and no receptor characterised. Those three findings are how a proposed endogenous peptide normally becomes accepted biology, and DSIP has none of them nearly fifty years after isolation.

Key facts

Gene
Not identified
Precursor protein
Not characterised
Receptor
Not identified
Time since isolation
Nearly 50 years
Consequence
No mechanism to test; no knockout possible
Contrast
MOTS-c, humanin (both gene-located)

How an endogenous peptide normally gets established

There is a recognisable sequence. A peptide is isolated and sequenced. Its gene is located, which explains where it comes from and how its production is regulated. A precursor protein is characterised, showing how it is processed. A receptor is identified, giving a mechanism and a target. At that point the peptide has a place in physiology rather than a suggestive result attached to it.

What DSIP has and has not

It has an isolation, a sequence, a synthesis and a large literature. It does not have a gene, a precursor or a receptor. Each absence is individually surmountable (plenty of molecules waited decades for a receptor), but the combination, sustained across nearly fifty years of active interest, is unusual and is the single most informative fact about the compound.

Research material referenced

DSIP 5mg, third-party HPLC tested

Buy DSIP · £13.95

Why a missing receptor is the hardest gap

A receptor is what makes a mechanism testable. With one, you can measure binding, build dose-response relationships, design antagonists and establish whether an observed effect actually runs through the proposed pathway. Without one, an observed effect can only be described, not explained, and cannot be distinguished from action through some entirely different route.

Why a missing gene is the hardest to explain

Modern genomics is very good at finding coding sequences. MOTS-c was located inside the mitochondrial 12S rRNA gene in 2015: a short open reading frame nested inside sequence already annotated as something else, and it was still found. That a putative endogenous peptide first described in 1977 has no identified gene in the genomic era is a substantive observation about its likely status.

What this does not prove

Absence of evidence is not proof of absence. It remains possible that DSIP has an endogenous role yet to be characterised. The honest position is not that DSIP has been refuted but that it has never been established, and that the specific gaps are the ones that would matter most.

How to weigh it against the published literature

When a study reports an effect of administered DSIP, that effect is being produced by a synthetic peptide at an experimentally chosen concentration through an unknown mechanism. That can still be a real and interesting observation. It is not evidence that the compound performs a physiological function, and the two claims should not be reported as one.

Frequently asked questions

Could a DSIP receptor still be found?

Possible. Receptors have been identified decades after their ligands. But sustained failure across nearly fifty years is itself informative.

Does no gene mean DSIP is not endogenous?

It means it has not been established as endogenous. That is a weaker statement than refutation, and a much weaker one than the name implies.

How does this compare with other research peptides?

MOTS-c and humanin both have identified coding sequences in the mitochondrial genome. DSIP has none in any genome, which is the clearest contrast available.

Continue researching

Related guides and reference material.

Primary sources & clinical trials

Published papers, trial registrations, regulator pages and company announcements. Links open the original.

Browse the wider literature

Live database searches, not fixed citations. Results change as new work is indexed.

UKP

Written and published by UK Peptides, the trading name of AURYXRESEARCH LTD (company 17388727, registered in England and Wales).

Questions or a correction? Email hello@ukpeptides.org or call +44 7426 987848.

Corrections log

More DSIP (Delta Sleep-Inducing Peptide) articles

Research use only. The information above is provided for scientific and educational reference. Compounds referenced are not approved for human use and are supplied for in vitro research or reference-material purposes only. No efficacy, safety, or therapeutic claims are made.